PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'State Key Lab of Microbial Metabolism, Department of Bioinformatics and Biological Statistics, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China.\', \'Center for Biotechnology and Microbiology, University of Swat, Swat, Pakistan.\', \'National Center for Bioinformatics, Quaid-i-Azam University, Islamabad, Pakistan.\', \'Center for Viticulture and Enology, School of Agriculture and Biology, Shanghai Jiao Tong University, Shanghai, China.\', \'The CAS Key Laboratory of Innate Immunity and Chronic Diseases, Hefei National Laboratory for Physical Sciences at Microscale, School of Life Sciences, CAS Center for Excellence in Molecular Cell Science, University of Science and Technology of China (USTC), Collaborative Innovation Center of Genetics and Development, Hefei, China.\', \'State Key Laboratory of Microbial Metabolism, Shanghai-Islamabad-Belgrade Joint Innovation Center on Antibacterial Resistances, Joint Laboratory of International Cooperation in Metabolic and Developmental Sciences, Ministry of Education and School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, P.R. China.\', \'Peng Cheng Laboratory, Shenzhen, P.R. China.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1080/07391102.2020.1779128
?:hasPublicationType
?:journal
  • Journal of biomolecular structure & dynamics
is ?:pmid of
?:pmid
?:pmid
  • 32552361
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Combined drug repurposing and virtual screening strategies with molecular dynamics simulation identified potent inhibitors for SARS-CoV-2 main protease (3CLpro).
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all